文献速递头颈与中枢神经肿瘤

凋亡能力与头颈部鳞状细胞癌风险

Apoptotic capacity and risk of squamous cell carcinoma of the head and neck.
PubMed 文献 · Eur J Cancer · 2016-12-26

在708例头颈部鳞状细胞癌(SCCHN)患者和685例匹配的无癌对照中,采用流式细胞术检测外周血淋巴细胞经喜树碱(CPT)诱导的凋亡能力。病例组平均凋亡能力45.9±23.3%显著低于对照组49.0±23.1%(P=0.002);以对照组中位水平为 cutoff,凋亡能力降低者SCCHN风险升高(调整OR=1.42,95%CI 1.13-1.78,P=0.002)。

要点

  • 病例组CPT诱导的凋亡能力均值45.9±23.3%,低于对照组49.0±23.1%(P=0.002)。
  • 凋亡能力低于对照组中位水平者SCCHN风险升高(调整OR=1.42,95%CI 1.13-1.78)。
  • 年龄≥57岁、男性、曾饮酒者中凋亡能力与SCCHN风险存在显著交互作用。

核心结论

  • 凋亡能力降低的个体可能具有更高的SCCHN发病风险,凋亡能力可能作为SCCHN易感性生物标志物。

研究设计与样本

  • 病例对照研究,纳入708例SCCHN患者和685例匹配的无癌对照,为北美人群。
  • 用流式细胞术检测培养的外周血淋巴细胞在体外暴露于喜树碱(CPT)后的凋亡能力。

主要发现

  • 病例组凋亡能力均值45.9±23.3%,低于对照组49.0±23.1%(P=0.002)。
  • 以对照组凋亡能力中位水平为cutoff,凋亡能力降低者SCCHN风险升高(调整OR=1.42,95%CI 1.13-1.78,P=0.002)。
  • 年龄≥57岁者中凋亡能力降低与SCCHN风险升高相关(OR=1.73,95%CI 1.25-2.38,P=0.0009),且与凋亡能力交互作用P=0.015。
  • 男性中凋亡能力降低与SCCHN风险升高相关(OR=1.76,95%CI 1.36-2.27,P<0.0001),交互作用P=0.005。
  • 曾饮酒者中凋亡能力降低与SCCHN风险升高相关(OR=1.67,95%CI 1.27-2.21,P=0.0003),交互作用P=0.009。

关键数值与推荐

  • 以对照组凋亡能力中位水平为cutoff计算调整OR。
  • 凋亡能力降低者SCCHN调整OR=1.42(95%CI 1.13-1.78,P=0.002)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tobacco smoke and alcohol drinking are the major risk factors for squamous cell carcinoma of the head and neck (SCCHN). Smoking and drinking cause DNA damage leading to apoptosis, and insufficient apoptotic capacity may favour development of cancer because of the dysfunction of removing damaged cells. In the present study, we investigated the association between camptothecin (CPT)-induced apoptotic capacity and risk of SCCHN in a North American population. METHODS: In a case-control study of 708 SCCHN patients and 685 matched cancer-free controls, we measured apoptotic capacity in cultured peripheral blood lymphocytes in response to in vitro exposure to CPT by using the flow cytometry-based method. RESULTS: We found that the mean level of apoptotic capacity in the cases (45.9 ± 23.3%) was significantly lower than that in the controls (49.0 ± 23.1%) (P = 0.002). When we used the median level of apoptotic capacity in the controls as the cutoff value for calculating adjusted odds ratios, subjects with a reduced apoptotic capacity had an increased risk (adjusted odds ratio = 1.42, 95% confidence interval = 1.13-1.78, P = 0.002), especially for those who were age ≥57 (1.73, 1.25-2.38, 0.0009), men (1.76, 1.36-2.27, <0.0001) and ever drinkers (1.67, 1.27-2.21, 0.0003), and these variables significantly interacted with apoptotic capacity (Pinteraction = 0.015, 0.005 and 0.009, respectively). A further fitted prediction model suggested that the inclusion of apoptotic capacity significantly improved in the prediction of SCCHN risk. CONCLUSION: Individuals with a reduced CPT-induced apoptotic capacity may be at an increased risk of developing SCCHN, and apoptotic capacity may be a biomarker for susceptibility to SCCHN.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Liu Z, Liu H, Han P, et al. Apoptotic capacity and risk of squamous cell carcinoma of the head and neck. Eur J Cancer. 2016. PMID: 28033527. doi:10.1016/j.ejca.2016.11.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。